Surface sterilisation by misting with a bioflavanoid solution

Abstract

There is described a method of sterilizing surfaces using flavanoids, for example mixtures containing inter alia naringin and neohesperidin, by misting.

1 . A method of sterilizing a surface of a medical establishment, a medical equipment, or ambulances, comprising misting the said surface with a composition having an effective amount of a mixture of bioflavonoids which comprises 40% to 65% of naringin and 20% to 35% neohesperidin. 
     
     
         2 - 8 . (canceled) 
     
     
         9 . The method as claimed in  claim 1 , wherein the mixture comprises at least 75% of neohesperidine and naringin. 
     
     
         10 - 13 . (canceled) 
     
     
         14 . The method as claimed in  claim 1 , wherein the method is for sterilizing surfaces of a medical establishment, and wherein the medical establishment is a hospital ward, theatre, corridor or waiting area. 
     
     
         15 - 16 . (canceled) 
     
     
         17 . The method as claimed in  claim 1 , wherein misting is employed to aid prevention of spread of methicillin resistant  staphylococcus aureus.    
     
     
         18 . The method as claimed in  claim 1 , wherein misting is employed to aid prevention of spread of  clostridium difficile.    
     
     
         19 . The method as claimed in  claim 1 , wherein the composition further comprises a surfactant. 
     
     
         20 . The method as claimed in  claim 19 , wherein the composition comprises a mixture of flavanoids together with residues of extraction from bitter oranges. 
     
     
         21 . The method as claimed in  claim 1 , wherein the mixture of flavanoids comprises HPLC-45%. 
     
     
         22 . The method as claimed in  claim 1 , wherein the surfaces is exposed to the composition for 2 minutes to 20 minutes. 
     
     
         23 . (canceled) 
     
     
         24 . The method as claimed in  claim 1 , wherein the ambulance may be occupied during treatment or may be re-occupied promptly following treatment. 
     
     
         25 . (canceled) 
     
     
         26 . The method as claimed in  claim 1 , wherein misting is employed to aid prevention of spread of  helicobacter pyroli.    
     
     
         27 . The method as claimed in  claim 1 , wherein misting is employed to aid prevention of spread of vancomycin resistant enterobacteria. 
     
     
         28 . The method as claimed in  claim 1 , wherein the misting is in the form of droplets of between 0.5 to 5μ.